Table 1 Demographic and clinical characteristics of the study cohort.
Characteristic | HIV-negative (n = 34) | HIV-positive (n = 43) | |
|---|---|---|---|
Years of infectionα | 0 | 14 (9.5–21.0) | |
ART use duration (months)α | 0 | 29.1 (11.7–75.1) | |
Age (years)α | 53.5 (48.2–56.7) | 48.1 (43.4–51.0) | |
Gender (% male) | 64.7 | 69.7 | |
Race (%) | White | 35 | 39.5 |
Non-white | 65 | 60.5 | |
CD4 count (cells/µl)α | — | 342 (195–461.5) | |
Nadir CD4 (cells/µl)α | — | 83.5 (28.7–288.5) | |
CD8 count (cells/µl)α | — | 836.5 (719–1357) | |
CD4/CD8 ratioα | — | 0.25 (0.12–0.46) | |
Plasma viral load (HIV RNA copies/ml)α | — | 404 (40–926.5) | |
Viral load <400 HIV RNA copies/mlγ (%) | — | 53.5 | |
HCV seropositive (%) | — | 42 | |
Cocaine use (%)β | — | 49 | |
Alcohol use (%)β | — | 40 | |
Smoking (%) | 79 | 70 | |
